Rosemary A Crane's Net Worth
$3.85 Million
Who is Rosemary A Crane?
Rosemary A Crane has an estimated net worth of $3.85 Million. This is based on reported shares across multiple companies, which include Catalent, Inc., Targanta Therapeutics Corp., Tarsus Pharmaceuticals, Inc., TEVA PHARMACEUTICAL INDUSTRIES LTD, Edge Therapeutics, Inc., MELA SCIENCES, INC. /NY, Certara, Inc., Unilife Corp, and EPOCRATES INC.
SEC CIK
Rosemary A Crane's CIK is 0001443343
Past Insider Trading and Trends
2023 was Rosemary A Crane's most active year for acquiring shares with 8 total transactions. Rosemary A Crane's most active month to acquire stocks was the month of May. 2023 was Rosemary A Crane's most active year for disposing of shares, totalling 3 transactions. Rosemary A Crane's most active month to dispose stocks was the month of May. 2014 saw Rosemary A Crane paying a total of $50,001.80 for 67,570 shares, this is the most they've acquired in one year. In 2024 Rosemary A Crane cashed out on 33,121 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Catalent, Inc. (CTLT) Snapshot price: $60.01
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +41.43% | 6.99K |
—
|
—
| 23.87K |
Oct 27
| |||
Form 4
| +32.59% | 4.15K |
—
|
—
| 16.88K |
Oct 27
| |||
Form 4
| +12.38% | 1.4K |
—
|
—
| 12.73K |
Oct 28
| |||
Form 4
| +23.09% | 2.13K |
—
|
—
| 11.33K |
Oct 29
| |||
Form 4
| +7.74% | 661 |
—
|
—
| 9.2K |
Aug 27
| |||
Form 4
| +58.91% | 3.17K |
—
|
—
| 8.54K |
Aug 22
| |||
Form 4
| +350.63% | 4.18K |
—
|
—
| 5.38K |
Aug 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Targanta Therapeutics Corp. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Tarsus Pharmaceuticals, Inc. (TARS) Snapshot price: $30.59
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +167.50% | 3.35K |
—
|
—
| 5.35K |
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
∞
| 2K |
—
|
—
| 2K |
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Snapshot price: $18.06
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +25.58% | 21.11K |
—
|
—
| 103.61K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
| +23.70% | 15.81K |
—
|
—
| 82.51K |
Aug 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 4
| |||
Form 4
| +27.73% | 14.48K |
—
|
—
| 66.7K |
Jun 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Edge Therapeutics, Inc. (PDSB) Snapshot price: $2.91
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 10K |
—
|
—
| 10K |
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |